JP2019089834A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019089834A5 JP2019089834A5 JP2019026743A JP2019026743A JP2019089834A5 JP 2019089834 A5 JP2019089834 A5 JP 2019089834A5 JP 2019026743 A JP2019026743 A JP 2019026743A JP 2019026743 A JP2019026743 A JP 2019026743A JP 2019089834 A5 JP2019089834 A5 JP 2019089834A5
- Authority
- JP
- Japan
- Prior art keywords
- apoe mimetic
- treatment cycle
- pharmaceutical composition
- rest period
- apoe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361782956P | 2013-03-14 | 2013-03-14 | |
| US61/782,956 | 2013-03-14 | ||
| US201361834992P | 2013-06-14 | 2013-06-14 | |
| US61/834,992 | 2013-06-14 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502527A Division JP6570511B2 (ja) | 2013-03-14 | 2014-03-14 | アポリポタンパク質模倣体及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019089834A JP2019089834A (ja) | 2019-06-13 |
| JP2019089834A5 true JP2019089834A5 (https=) | 2019-10-31 |
| JP6772317B2 JP6772317B2 (ja) | 2020-10-21 |
Family
ID=51581312
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502527A Expired - Fee Related JP6570511B2 (ja) | 2013-03-14 | 2014-03-14 | アポリポタンパク質模倣体及びその使用 |
| JP2019026743A Expired - Fee Related JP6772317B2 (ja) | 2013-03-14 | 2019-02-18 | アポリポタンパク質模倣体及びその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502527A Expired - Fee Related JP6570511B2 (ja) | 2013-03-14 | 2014-03-14 | アポリポタンパク質模倣体及びその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20160002315A1 (https=) |
| EP (1) | EP2996706B1 (https=) |
| JP (2) | JP6570511B2 (https=) |
| AU (2) | AU2014239186B2 (https=) |
| BR (1) | BR112015022624A2 (https=) |
| CA (1) | CA2903869A1 (https=) |
| DK (1) | DK2996706T3 (https=) |
| ES (1) | ES2753381T3 (https=) |
| IL (1) | IL240787B (https=) |
| MX (1) | MX2015012818A (https=) |
| NZ (1) | NZ713291A (https=) |
| WO (1) | WO2014152776A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX383117B (es) | 2014-07-31 | 2025-03-13 | Anji Pharmaceuticals Inc | Péptidos miméticos de la apoe y mayor potencia para depurar el colesterol en plasma. |
| WO2017120568A1 (en) * | 2016-01-08 | 2017-07-13 | Lipimetix Development, Inc. | Apoe mimetic peptide compositions |
| PL3416684T3 (pl) * | 2016-02-17 | 2023-11-06 | Regeneron Pharmaceuticals, Inc. | Sposoby leczenia lub profilaktyki miażdżycy tętnic przez podawanie inhibitora angptl3 |
| JP7541810B2 (ja) | 2016-03-03 | 2024-08-29 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | Ａｎｇｐｔｌ３阻害剤と組み合わせてｐｃｓｋ９阻害剤を投与することにより高脂血症を有する患者を処置するための方法 |
| US12559551B2 (en) | 2019-05-24 | 2026-02-24 | Regeneron Pharmaceuticals, Inc. | Stabilized formulations containing anti-ANGPTL3 antibodies |
| WO2023018876A2 (en) * | 2021-08-11 | 2023-02-16 | The Regents Of The University Of California | Barrier function preserving peptides for membranes |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO812612L (no) | 1980-08-06 | 1982-02-08 | Ferring Pharma Ltd | Enzym-inhibitorer. |
| GB9022788D0 (en) | 1990-10-19 | 1990-12-05 | Cortecs Ltd | Pharmaceutical formulations |
| US5331573A (en) | 1990-12-14 | 1994-07-19 | Balaji Vitukudi N | Method of design of compounds that mimic conformational features of selected peptides |
| US5631280A (en) | 1995-03-29 | 1997-05-20 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US6506880B2 (en) | 1998-03-17 | 2003-01-14 | The Uab Research Foundation | Synthetic peptides that enhance atherogenic lipoprotein uptake and lower plasma cholesterol |
| US6664230B1 (en) | 2000-08-24 | 2003-12-16 | The Regents Of The University Of California | Orally administered peptides to ameliorate atherosclerosis |
| US7199102B2 (en) | 2000-08-24 | 2007-04-03 | The Regents Of The University Of California | Orally administered peptides synergize statin activity |
| US8557767B2 (en) * | 2007-08-28 | 2013-10-15 | Uab Research Foundation | Synthetic apolipoprotein E mimicking polypeptides and methods of use |
| US20130005645A1 (en) * | 2010-01-06 | 2013-01-03 | Vitek Michael P | Apoe peptide dimers and uses thereof |
| MX383117B (es) * | 2014-07-31 | 2025-03-13 | Anji Pharmaceuticals Inc | Péptidos miméticos de la apoe y mayor potencia para depurar el colesterol en plasma. |
-
2014
- 2014-03-14 EP EP14769489.7A patent/EP2996706B1/en active Active
- 2014-03-14 CA CA2903869A patent/CA2903869A1/en not_active Abandoned
- 2014-03-14 NZ NZ713291A patent/NZ713291A/en not_active IP Right Cessation
- 2014-03-14 BR BR112015022624A patent/BR112015022624A2/pt not_active Application Discontinuation
- 2014-03-14 US US14/770,270 patent/US20160002315A1/en not_active Abandoned
- 2014-03-14 DK DK14769489.7T patent/DK2996706T3/da active
- 2014-03-14 JP JP2016502527A patent/JP6570511B2/ja not_active Expired - Fee Related
- 2014-03-14 AU AU2014239186A patent/AU2014239186B2/en not_active Ceased
- 2014-03-14 ES ES14769489T patent/ES2753381T3/es active Active
- 2014-03-14 MX MX2015012818A patent/MX2015012818A/es active IP Right Grant
- 2014-03-14 WO PCT/US2014/027719 patent/WO2014152776A1/en not_active Ceased
-
2015
- 2015-08-24 IL IL240787A patent/IL240787B/en active IP Right Grant
-
2017
- 2017-06-09 AU AU2017203911A patent/AU2017203911B2/en not_active Ceased
-
2019
- 2019-02-18 JP JP2019026743A patent/JP6772317B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019089834A5 (https=) | ||
| JP2009530395A5 (https=) | ||
| JP2010529128A5 (https=) | ||
| JP2014521684A5 (https=) | ||
| JP2010540654A5 (https=) | ||
| JP2013509435A5 (https=) | ||
| BRPI0716261A2 (pt) | composiÇÕes farmacÊuticas compreendendo hch para distribuiÇço oral | |
| IL250302B (en) | Apoe mimetic peptides and higher potency to clear plasma cholesterol | |
| JP2015520188A5 (https=) | ||
| JP2016515137A5 (https=) | ||
| JP2010518079A5 (https=) | ||
| KR20140095479A (ko) | 비염의 치료 | |
| FI3065763T4 (fi) | Il-22-dimeerin käyttö lääkkeen valmistamisessa suonensisäistä antoa varten | |
| JP2021514003A5 (https=) | ||
| JP2015524802A5 (https=) | ||
| HRP20110386T1 (hr) | Sintetička sekvenca mecp2 za zamjensku proteinsku terapiju | |
| JP2018531945A (ja) | 免疫系を刺激するためのペプチドの使用 | |
| JP2018515459A (ja) | 自己免疫障害及び炎症障害を治療及び／又は予防するための短い合成ペプチド | |
| CA2470656A1 (en) | Corticotropin releasing factor 2 receptor agonists | |
| JPH06507386A (ja) | 治療用ペプチド | |
| JP7353973B2 (ja) | Ａｐｏｃ－ｉｉ模倣ペプチド | |
| JP2004513079A5 (https=) | ||
| JP2013506682A5 (https=) | ||
| US12552848B2 (en) | Hydrochloride salts of C5a receptor agonist peptides | |
| JP2020531586A5 (https=) |